Thus, while Fzd5 expression is variable in non-melanoma skin cancer cells, its expression level in tumor-vessels is consistent with a role of this receptor in mediating Wnt5a-dependent inflammatory pathways, consistent with previous reports [20], [21]. The gene discussed is WNT5A; the disease is neoplasm.